This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Hanh Bui, PharmD
Advertisement
Articles by Hanh Bui, PharmD
Advertisement
Latest Updated Articles
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid TumorsPublished: February 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
2
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
3
Immunization and Vigilance: Preventing Infections in T-Cell Modifying Therapies
4
What to Know About the Latest Pediatric Respiratory Infections
5
